If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Login
Sign Up
Advanced Search
Newsfeed
Followed Companies
Email Settings
Follow
Articles
All
News
Blogs
Videos
Press Releases
Leap Therapeutics Articles
January 4, 2021
MarketScreener
News
to Present at 39th Annual J.P. Morgan Healthcare Conference
(marketscreener.com) CAMBRIDGE, Mass., Jan. 4, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. , a biote...
See more »
December 22, 2020
PR Newswire
Press Release
Leap Therapeutics Announces Publication of DKN-01 Mechanism of Action Data in Molecular Cancer Research
CAMBRIDGE, Mass., Dec. 22, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnolog...
See more »
November 12, 2020
BioSpace
News
Leap Therapeutics Reports Third Quarter 2020 Financial Results
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and imm...
See more »
November 10, 2020
MarketScreener
News
to Present at Stifel 2020 Healthcare Conference
(marketscreener.com) CAMBRIDGE, Mass., Nov. 10, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biot...
See more »
October 15, 2020
PR Newswire
Press Release
Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual Meeting
CAMBRIDGE, Mass., Oct. 15, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnolog...
See more »
September 25, 2020
Seeking Alpha
News
The Good, Bad And Ugly Of Biopharma
See more »
September 24, 2020
PR Newswire
Press Release
Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing ...
See more »
September 15, 2020
Seeking Alpha
News
Leap Therapeutics files for $150M mixed shelf
See more »
September 9, 2020
MarketScreener
News
to Present at H.C. Wainwright 22nd Annual Global Investment Conference
(marketscreener.com) CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biot...
See more »
August 24, 2020
MarketScreener
News
Expands Leadership Team with Addition of Two Industry Veterans
(marketscreener.com) CAMBRIDGE, Mass., Aug. 24, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biot...
See more »
August 16, 2020
Zolmax News
News
Leap Therapeutics Inc (NASDAQ:LPTX) Expected to Announce Earnings of -$0.17 Per Share
Brokerages forecast that Leap Therapeutics Inc (NASDAQ:LPTX) will post earnings per share (EPS) of ($...
See more »
August 13, 2020
BioSpace
News
Leap Therapeutics Reports Second Quarter 2020 Financial Results
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology t...
See more »
July 1, 2020
Zolmax News
News
Leap Therapeutics Inc (NASDAQ:LPTX) Expected to Post Earnings of -$0.26 Per Share
Equities research analysts expect Leap Therapeutics Inc (NASDAQ:LPTX) to report ($0.26) earnings per ...
See more »
February 4, 2020
PR Newswire
Press Release
Leap Therapeutics to Present at 22nd Annual BIO CEO & Investor Conference
CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnolog...
See more »
January 23, 2020
centralcharts
Press Release
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI)...
See more »
September 17, 2019
PR Newswire
Press Release
Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination at the 2019 International Gynecologic Cancer Society Annual Global Meeting
CAMBRIDGE, Mass., Sept. 17, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX) today announc...
See more »
April 3, 2019
PR Newswire
Press Release
Leap Therapeutics to Present at the 2019 Needham & Company 18th Annual Healthcare Conference
CAMBRIDGE, Mass., April 3, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnolo...
See more »
April 1, 2019
PR Newswire
Press Release
Leap Therapeutics Reports Clinical Update and 2018 Financial Results
CAMBRIDGE, Mass., April 1, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnolo...
See more »
March 18, 2019
PR Newswire
Press Release
Leap Therapeutics Presents at Society of Gynecologic Oncology 50th Annual Meeting on Women's Cancer
CAMBRIDGE, Mass., March 18, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX) today announce...
See more »
March 8, 2019
centralcharts
Press Release
Leap Therapeutics to Present at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer
CAMBRIDGE, Mass., March 8, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnolo...
See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...